Imbimbo BP - Search Results

1

The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset.

Panza F, Seripa D, Lozupone M, Solfrizzi V, Imbimbo BP, Barulli MR, Tortelli R, Capozzo R, Bisceglia P, Dimitri A, Stallone R, Dibello V, Quaranta N, Daniele A, Bellomo A, Greco A, Logroscino G. Panza F, et al. Among authors: imbimbo bp. Expert Opin Biol Ther. 2018 Jan;18(1):25-35. doi: 10.1080/14712598.2018.1389885. Epub 2017 Oct 16. Expert Opin Biol Ther. 2018. PMID: 29037101 Review.

2

The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.

Imbimbo BP. Imbimbo BP. Expert Opin Investig Drugs. 2004 Nov;13(11):1469-81. doi: 10.1517/13543784.13.11.1469. Expert Opin Investig Drugs. 2004. PMID: 15500394 Review.

3

Pathophysiology of Alzheimer's disease.

Imbimbo BP, Lombard J, Pomara N. Imbimbo BP, et al. Neuroimaging Clin N Am. 2005 Nov;15(4):727-53, ix. doi: 10.1016/j.nic.2005.09.009. Neuroimaging Clin N Am. 2005. PMID: 16443487 Review.

4

Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.

Moretto N, Bolchi A, Rivetti C, Imbimbo BP, Villetti G, Pietrini V, Polonelli L, Del Signore S, Smith KM, Ferrante RJ, Ottonello S. Moretto N, et al. Among authors: imbimbo bp. J Biol Chem. 2007 Apr 13;282(15):11436-45. doi: 10.1074/jbc.M609690200. Epub 2007 Jan 31. J Biol Chem. 2007. PMID: 17267402 Free article.

5

Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review.

Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Di Palo A, Imbimbo BP, Vendemiale G, Capurso A, Solfrizzi V. Panza F, et al. Among authors: imbimbo bp. ScientificWorldJournal. 2009 May 22;9:373-89. doi: 10.1100/tsw.2009.48. ScientificWorldJournal. 2009. PMID: 19468660 Free PMC article. Review.

6

Why did tarenflurbil fail in Alzheimer's disease?

Imbimbo BP. Imbimbo BP. J Alzheimers Dis. 2009;17(4):757-60. doi: 10.3233/JAD-2009-1092. J Alzheimers Dis. 2009. PMID: 19542625

7

Semagacestat, a gamma-secretase inhibitor for the potential treatment of Alzheimer's disease.

Imbimbo BP, Peretto I. Imbimbo BP, et al. Curr Opin Investig Drugs. 2009 Jul;10(7):721-30. Curr Opin Investig Drugs. 2009. PMID: 19579178

8

An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.

Imbimbo BP. Imbimbo BP. Expert Opin Investig Drugs. 2009 Aug;18(8):1147-68. doi: 10.1517/13543780903066780. Expert Opin Investig Drugs. 2009. PMID: 19589092 Review.

9

Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators.

Panza F, Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Imbimbo BP. Panza F, et al. Among authors: imbimbo bp. Drugs Aging. 2009;26(7):537-55. doi: 10.2165/11315770-000000000-00000. Drugs Aging. 2009. PMID: 19655822 Review.

10

Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.

Capurso C, Solfrizzi V, Colacicco AM, D'Introno A, Frisardi V, Imbimbo BP, Lorusso M, Vendemiale G, Denitto M, Santamato A, Seripa D, Pilotto A, Fiore P, Capurso A, Panza F. Capurso C, et al. Among authors: imbimbo bp. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):177-82. doi: 10.1016/j.pnpbp.2009.10.022. Epub 2009 Nov 6. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19897004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters